VOLTAROL Medicated Plaster

Active ingredients: Diclofenac

Product name and form

Voltarol 140 mg Medicated Plaster.

Pharmaceutical Form

Medicated Plaster.

Voltarol 140 mg Medicated Plaster is a white 10x14 cm sized self-adhesive plaster made of non-woven fabric on one and paper on other side.

Qualitative and quantitative composition

Each medicated plaster contains 140 mg diclofenac sodium.

For the full list of excipients, see section 6.1.

Active Ingredient

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

List of Excipients

Supporting layer:

Polyester non-woven fabric

Adhesive layer:

Basic butylated methacrylate copolymer
Copolymer acrylate vinyl acetate
PEG 12stearate
Sorbitan oleate


Mono silicone coated paper

Pack sizes and marketing

Voltarol 140 mg medicated plasters are individually enclosed in sealed sachets of 145 × 228 mm made of paper/Alu/PEX laminate, provided with easy open and packed in a cardboard box.

Each pack contains 2, 5 or 10 medicated plasters.

Not all pack sizes may be marketed.

Marketing authorization holder

GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

Marketing authorization dates and numbers

PL 44673/0158



Estonia, Ireland, United Kingdom